HCG Hospitals Valuation Multiples

Discover HCG Hospitals' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Rhoen Klinikum, Clinica Baviera, Terveystalo, Life Healthcare Group and more.

HCG Hospitals Overview

About HCG Hospitals

HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company’s operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.


Founded

1998

HQ

India

Employees

5.8K

Financials (LTM)

Revenue: $275M
EBITDA: $51M

EV

$1.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

HCG Hospitals Financials

HCG Hospitals reported last 12-month revenue of $275M and EBITDA of $51M.

In the same LTM period, HCG Hospitals generated $201M in gross profit, $51M in EBITDA, and $6M in net income.

Revenue (LTM)


HCG Hospitals P&L

In the most recent fiscal year, HCG Hospitals reported revenue of $263M and EBITDA of $48M.

HCG Hospitals is profitable as of last fiscal year, with gross margin of 51%, EBITDA margin of 18%, and net margin of 1%.

See analyst estimates for HCG Hospitals
LTMLast FY202320242025202620272028
Revenue$275M$263M$190M$220M$254M
Gross Profit$201M$134M$99M$112M$130M
Gross Margin73%51%52%51%51%
EBITDA$51M$48M$34M$41M$46M
EBITDA Margin19%18%18%19%18%
EBIT Margin10%9%9%8%9%
Net Profit$6M$2M$5M$5M$2M
Net Margin2%1%2%2%1%
Net Debt-$39M---

Financial data powered by Morningstar, Inc.

HCG Hospitals Stock Performance

HCG Hospitals has current market cap of $1B, and enterprise value of $1.1B.

Market Cap Evolution


HCG Hospitals' stock price is $6.79.

HCG Hospitals share price increased by 2.6% in the last 30 days, and by 0.8% in the last year.

HCG Hospitals has an EPS (earnings per share) of $0.01.

See more trading valuation data for HCG Hospitals
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.1B$1B-0.8%2.6%12.5%0.8%$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

HCG Hospitals Valuation Multiples

HCG Hospitals trades at 4.1x EV/Revenue multiple, and 22.1x EV/EBITDA.

See NTM and 2027E valuation multiples for HCG Hospitals

EV / Revenue (LTM)


HCG Hospitals Financial Valuation Multiples

As of July 18, 2026, HCG Hospitals has market cap of $1B and EV of $1.1B.

HCG Hospitals has a P/E ratio of 178.1x.

LTMLast FY202320242025202620272028
EV/Revenue4.1x4.3x6.0x5.2x4.5x
EV/EBITDA22.1x23.6x32.9x27.6x24.9x
EV/EBIT43.2x48.2x68.4x61.1x51.5x
EV/Gross Profit5.7x8.4x11.5x10.1x8.8x
P/E178.1xn/m225.0x215.6xn/m
EV/FCF189.7x199.2x105.6x103.5x160.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified HCG Hospitals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

HCG Hospitals Margins & Growth Rates

HCG Hospitals grew revenue by 15% and EBITDA by 24% in the last fiscal year.

In the most recent fiscal year, HCG Hospitals reported gross margin of 51%, EBITDA margin of 18%, and net margin of 1%.

See estimated margins and future growth rates for HCG Hospitals

HCG Hospitals Margins

Last FY202420252026202720282029
Gross Margin51%51%51%69%
EBITDA Margin18%19%18%19%
EBIT Margin9%8%9%10%
Net Margin1%2%1%4%
FCF Margin2%5%3%4%

HCG Hospitals Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth15%16%16%15%
Gross Profit Growth66%14%16%55%
EBITDA Growth24%19%11%23%
EBIT Growth38%12%19%37%
Net Profit Growth595%4%(53%)397%
FCF Growth122%2%(35%)54%

Data powered by FactSet, Inc. and Morningstar, Inc.

HCG Hospitals Operational KPIs

HCG Hospitals' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

HCG Hospitals' Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

HCG Hospitals' Rule of X is 57% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for HCG Hospitals
LTMLast FY202320242025202620272028
Rule of 4034%34%---
Bessemer Rule of X57%57%---
Revenue per Employee-$0.0M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue--2%2%2%
G&A Expenses to Revenue-0%4%3%1%
Opex to Revenue-42%43%43%42%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Rhoen Klinikum0.4x0.4x5.9x5.8x
Clinica Baviera3.0x2.9x10.6x10.1x
Terveystalo1.1x1.2x5.8x6.2x
Life Healthcare Group0.8x0.8x5.2x4.8x
Thomson Medical6.1x-41.6x-
Dr. Sulaiman Al Habib Medical Services3.1x-11.3x-
Nutex Health1.4x1.4x4.4x5.3x
U.S. Physical Therapy1.9x1.8x13.3x14.6x

This data is available for Pro users. Sign up to see all HCG Hospitals competitors and their valuation data.

Start Free Trial

Acquisitions by HCG Hospitals

HCG Hospitals has acquired 1 company to date.

Last acquisition by HCG Hospitals was on April 5th 2017. HCG Hospitals acquired Cancer Care Kenya for $900K (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by HCG Hospitals

Cancer Care Kenya
Description
Cancer Care Kenya is a Nairobi-based comprehensive cancer center founded in 2010, treating over 1,000 patients annually including 200 internationals from East Africa. The facility offers radiotherapy with Varian TrueBeam, chemotherapy, and brachytherapy in a 5,000-square-meter site. Staff speak English, Swahili, Hindi, and Gujarati, partnering with Aga Khan University for training. Cancer Care Kenya introduced PET-CT scanning in 2018, expanding palliative services.
HQ CountryKenya
HQ City
Nairobi
Deal Date5 Apr 2017
Valuation$900K
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all HCG Hospitals acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About HCG Hospitals

When was HCG Hospitals founded?HCG Hospitals was founded in 1998.
Where is HCG Hospitals headquartered?HCG Hospitals is headquartered in India.
How many employees does HCG Hospitals have?As of today, HCG Hospitals has over 5K employees.
Who is the CEO of HCG Hospitals?HCG Hospitals' CEO is Manish Mattoo.
Is HCG Hospitals publicly listed?Yes, HCG Hospitals is a public company listed on National Stock Exchange of India.
What is the stock symbol of HCG Hospitals?HCG Hospitals trades under HCG ticker.
When did HCG Hospitals go public?HCG Hospitals went public in 2016.
Who are competitors of HCG Hospitals?HCG Hospitals main competitors include Rhoen Klinikum, Clinica Baviera, Terveystalo, Life Healthcare Group, Thomson Medical, Dr. Sulaiman Al Habib Medical Services, Nutex Health, U.S. Physical Therapy, Spire Healthcare Group, Saudi German Health.
What is the current market cap of HCG Hospitals?HCG Hospitals' current market cap is $1B.
What is the current revenue of HCG Hospitals?HCG Hospitals' last 12 months revenue is $275M.
What is the current revenue growth of HCG Hospitals?HCG Hospitals revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of HCG Hospitals?Current revenue multiple of HCG Hospitals is 4.1x.
What is the current EBITDA of HCG Hospitals?HCG Hospitals' last 12 months EBITDA is $51M.
What is HCG Hospitals' EBITDA margin?HCG Hospitals' last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of HCG Hospitals?Current EBITDA multiple of HCG Hospitals is 22.1x.
What is the current FCF of HCG Hospitals?HCG Hospitals' last 12 months FCF is $6M.
What is HCG Hospitals' FCF margin?HCG Hospitals' last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of HCG Hospitals?Current FCF multiple of HCG Hospitals is 189.7x.
How many companies HCG Hospitals has acquired to date?As of July 2026, HCG Hospitals has acquired 1 company.
What was the largest acquisition by HCG Hospitals?$900K acquisition of Cancer Care Kenya on 5th April 2017 was the largest M&A HCG Hospitals has done to date.
What companies HCG Hospitals acquired?HCG Hospitals acquired Cancer Care Kenya.
In how many companies HCG Hospitals has invested to date?HCG Hospitals hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to HCG Hospitals

Lists including HCG Hospitals

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial